Meeting Details

Article-based Exam: Embryo Aneuploidy is Not Impacted by Selective Serotonin Reuptake Inhibitor Exposure
Expiration Date:
February 1, 2021
Credits:
1.00 APA CE Credits
0.00 Certificate of Completion

It is estimated that approximately 10% of infertile women who are undergoing infertility treatment concurrently take antidepressant medication, most often selective serotonin reuptake inhibitors (SSRIs). Normal embryo development is a crucial step in successful IVF treatment and preimplantation genetic testing allows the opportunity to select normal blastocysts for transfer; embryo aneuploidy is one of the most common causes for treatment failure.  Thus, it is important to determine if SSRI use is associated with aneuploidy.  

This activity is based on the following: Embryo Aneuploidy is Not Impacted by Selective Serotonin Reuptake Inhibitor Exposure; Fernandez-Nieto C, Lee J, Nazem T, Gounko D, Copperman A, Sandler B. Fertil Steril 2017: 108: 973-9.

  • List Price: $29.00 USD
  • Member Price: Free

ACTIVITY NUMBER: MHP100

 

ACTIVITY TITLE:  Article-based Exam: Embryo Aneuploidy is Not Impacted by Selective Serotonin Reuptake Inhibitor Exposure

 

ACCREDITATION STATEMENTS

The Mental Health Professionals Group of the American Society for Reproductive Medicine is approved by the...

View More View Less

Google Tag Manager